Program overview of Sunday May 24

Sunday's program starts with a plenary session on Heart Disease:From Cradle to Coronary Care Unit and is concluded with a session on Heart Disease and Nutrition. Furthermore the program contains eight interesting X-Change sessions and many other events, such as the Chinese and Spanish Sessions and Industry Symposia.

Plenary Sessions

Morning Session | Heart Disease:

From Cradle to Coronary Care UnitPlenarySession

Chairpersons: Virgil Brown (Atlanta, USA) / Phil Barter (Sydney, Australia)

09:00 – 09:30 Epidemiology of CVD Kay Tee Khaw (Cambridge, UK)
09:30 – 10:00 CV Risk & Early Intervention John Deanfield (London, UK)
10:00 – 10:30 Genetics: Use in Causality CVD Sekar Kathiresan (Boston, USA)
10:30 – 11:00 LDL Lowering Therapies Evan Stein (Chicago, USA)

Afternoon Session | Controversies in Heart Disease and Nutrition:

Are We What We Eat?PlenarySession

Chairpersons: John Kastelein (Amsterdam, The Netherlands) / Jaap Seidell (Amsterdam, The Netherlands)

17:00 – 17:30 Paleolithic Diet Robb Wolf (Reno, USA)
17:30 – 18:00 Nutrition and CVD: Ten Steps Forward, Nine Steps Back Martijn Katan (Amsterdam, The Netherlands)

X-Change sessions

Morning X-Change SessionsXchangeSession

1. Epidemiology of CVD and Current Risk Stratification

Chairpersons: Hirotsugu Ueshima (Shiga, Japan) / Rick Grobbee (Utrecht, The Netherlands)

Risk Factors Kay Tee Khaw (Cambridge, UK)
Personalized Epidemiology Frank Visseren (Utrecht, The Netherlands)
Stratification for Therapy Colin Baigent (Oxford, UK)
2x 10 minutes Selected Abstracts  

2. Pathogenesis of Atherosclerosis

Chairpersons: Yasufumi Sato (Sendai, Japan) / Rob de Winter (Amsterdam, The Netherlands)

Inflammation Esther Lutgens (Amsterdam, The Netherlands)
Endothelium & Angiogenesis Peter Carmeliet (Leuven, Belgium)
Pros and Cons of Animal Models of Atherosclerosis Kylie Kavanagh (Winston-Salem, USA)
2x 10 minutes Selected Abstracts  

3. Novel Interventions in Blood Pressure Management

Resistant Hypertension: Fact or Fiction? TBD
ABPM and Central Blood Pressure: What does it add? Bryan Williams (London, UK)
BP Variability: Effect of Drugs and Impact on CV Outcome Peter Rothwell (Oxford, UK)
Genetics of Essential Hypertension Eric Sijbrands (Rotterdam, The Netherlands)

4. Novel Oral Anticoagulants

Chairpersons: Ron Peters (Amsterdam, The Netherlands) / Philippe-Gabriel Steg (Paris, France)

Atrial Fibrillation Gregory Lip (Birmingham, UK)
ACS & Secondary Prevention Keith Fox (Edinburgh, UK)
Deep Venous Thrombosis Harry Büller (Amsterdam, The Netherlands)
2x 10 minutes Selected Abstracts 2x 10 minutes Selected Abstracts

Afternoon X-Change SessionsXchangeSession

5. Diabetes and its Novel Interventions

Chairpersons: Max Nieuwdorp (Amsterdam, The Netherlands) / Jane Armitage (Oxford, UK)

Antidiabetic Drugs Nikolaus Marx (Aachen, Germany)
Hypolipidemic Drugs Naveed Sattar (Glasgow, UK)
Challenges controlling blood pressure in diabetes Thomas MacDonald (Dundee, UK)
2x 10 minutes Selected Abstracts 2x 10 minutes Selected Abstracts

6. PCSK9: From Biology to Therapy 

Chairpersons: Kees Hovingh (Amsterdam, The Netherlands) / Meral Kayıkçıoğlu (Izmir, Turkey)

The Biology of PCSK9 Gilles Lambert (Nantes, France)
Genetics Helen Hobbs (Dallas, USA)
Therapy Philippe-Gabriel Steg (Paris, France)
PCSK9: A Key Modulator of Cardiovascular Health Nabil Seidah (Montreal, Canada)

6. Imaging & Atherosclerosis 

Chairpersons: Anton Stalenhoef (Nijmegen, The Netherlands) / Ahmed Tawakol (Boston, USA)

IVUS, OCT & NIRS Steve Nissen (Cleveland, USA)
DCE – MRI and Multislice CT Zahi Fayad (New York, USA)
PET-CT James Rudd (Cambridge, UK)
Molecular Targeting of the Arterial Wall Erik Stroes (Amsterdam, The Netherlands)

8. Inflammation, the Immune System & Atherosclerosis

Chairpersons: Peter Carmeliet (Leuven, Belgium) / Peter Libby (Boston, USA)

Trained Immunity Mihai Netea (Nijmegen, The Netherlands)
Immunology Jon Laman (Rotterdam, The Netherlands)
The Pro-Inflammatory State as a Risk Factor for Atherogenesis Wolfgang Koenig (Ulm, Germany)
Therapeutic Intervention Paul Ridker (Boston, USA)

Schedule of Sunday May 24

Stay up to date, subscribe to the newsletter

Progression and prevention of atherosclerosis and a translation to relevance.